Difference between revisions of "Team:Bristol/Results"

 
Line 9: Line 9:
 
       <div class="banner-text-sm">
 
       <div class="banner-text-sm">
 
         <h1 class="Up">Results</h1>
 
         <h1 class="Up">Results</h1>
         <p class="Up">In Development</p>
+
         <p class="Up">Substance &lt; style... oh wait</p>
 
       </div>
 
       </div>
 
     </div>
 
     </div>
 
     <div class="fadeIn">
 
     <div class="fadeIn">
       <p class="lead Up">Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
+
       <p class="lead Up">Here we show our PCR results, and the conditions used, for the fragments which we subsequently used in Gibson assembly, as well as the sequencing results for our part, NrfB.</p>
        dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.</p>
+
 
     </div>
 
     </div>
  

Latest revision as of 18:57, 1 November 2017

Here we show our PCR results, and the conditions used, for the fragments which we subsequently used in Gibson assembly, as well as the sequencing results for our part, NrfB.


PCR results

The following table shows the final conditions used for successful PCR:


An agarose gel of final fragment PCR products is shown below:



Sequencing results

We successfully performed PCR on our fragments with our editing primers, to isolate the whole coding regions. Sequencing of our constructs showed that most had significant deletions and insertions of unknown DNA, however one construct, NrfB pSB1C3, had only one point mutation (shown below). We submitted this part (see our Parts page), annotating the mutation so future teams can take it into consideration when ordering the part. The part can still be used accurately if this mutation is edited, either molecularly, or through DNA synthesis.